Your browser doesn't support javascript.
Increased usage of the high flow nasal cannula in COVID-19 cases in Japan -from the online questionnaire survey by the Japanese Respiratory Society.
Tomii, Keisuke; Terada, Jiro; Chin, Kazuo.
  • Tomii K; Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminami-machi, Chuo-ku, Kobe, 650-0047, Japan. Electronic address: ktomii@kcho.jp.
  • Terada J; Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan; Department of Pulmonary Medicine, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita City, Chiba, 286-8520, Japan.
  • Chin K; Japanese Respiratory Society Scientific Assembly of Respiratory Care, Nichinai Building., 7F, 3-28-8, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan; Department of Sleep Medicine and Respiratory Care, Division of Sleep Medicine, Nihon University School of Medicine, 30-1 Ohyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.
Respir Investig ; 59(5): 666-669, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1267906
ABSTRACT
An online questionnaire survey was used to assess the application of noninvasive strategies in the management of COVID-19 patients. We found a marked increase in the proportion of facilities using high flow nasal cannula (HFNC) oxygen therapy successfully in the 3rd epidemic wave as compared to the 1st wave (49% vs. 12%) and rare reports of associated nosocomial infection in the medical personnel. Furthermore, the proportion of facilities using HFNC as first-line therapy for half or more than half of their patients who did not respond to conventional oxygen therapy increased from 9% in the first to 33% in the second survey. Conversely, the rate of mechanical ventilation with intubation usage following conventional oxygen therapy failure decreased from 62% to 54%. These changes could be due to the limited medical resources available during the larger 3rd wave coupled with increased internal reports on the success of HFNC.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Noninvasive Ventilation / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Country/Region as subject: Asia Language: English Journal: Respir Investig Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Noninvasive Ventilation / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Country/Region as subject: Asia Language: English Journal: Respir Investig Year: 2021 Document Type: Article